Default: Multidisciplinary Respiratory Medicine

ISSN: 1828-695X

Journal Home

Journal Guideline

Multidisciplinary Respiratory Medicine Q2 Unclaimed

Mattioli 1885 United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Multidisciplinary Respiratory Medicine is a journal indexed in SJR in Pulmonary and Respiratory Medicine with an H index of 42. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1507 €. The scope of the journal is focused on pulmonary medicine. It has an SJR impact factor of 0,617 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,617.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

1507 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Multidisciplinary Respiratory Medicine

0,617

SJR Impact factor

42

H Index

22

Total Docs (Last Year)

104

Total Docs (3 years)

795

Total Refs

227

Total Cites (3 years)

101

Citable Docs (3 years)

1.91

Cites/Doc (2 years)

36.14

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Novel aspects in diagnostic approach to respiratory patients: is it the time for a new semiotics?

View more

Clinical course and management of idiopathic pulmonary fibrosis

View more

Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections

View more

The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models

View more

Venous thromboembolism and lung cancer: a review

View more

JAK2 V617F mutation negative erythrocytosis (or how to more simply perform diagnosis and treat a patient with increased hematocrit)

View more

State of the art in tracheal surgery: a brief literature review

View more

Interobserver variability of ventilatory anaerobic threshold in asymptomatic volunteers

View more

Time for physicians to be aware of molecular genetic testing

View more

Immunostimulants in respiratory diseases: focus on Pidotimod

View more

Influenza and influenza-like syndromes: the subjects' beliefs, the attitude to prevention and treatment, and the impact in Italian general population

View more

Study of the role of exhaled nitric oxide (NO) in predicting controlled or uncontrolled asthma in asthmatic children

View more
SHOW MORE ARTICLES

Bronchiectasis in PCD looks different to CF on CT scan

View more

Endoscopic posterior cordotomy for treatment of dyspnea due to vocal fold immobility

View more

Motivation and response rates in bronchoscopy studies

View more

Opinions of healthcare providers on the design of a smartphone application for asthma treatment in the Kingdom of Saudi Arabia

View more

When to perform a bronchial challenge with mannitol?

View more

Examining the social status, risk factors and lifestyle changes of tuberculosis patients in Sri Lanka during the treatment period: a cross-sectional study

View more

The physiological basis and clinical significance of lung volume measurements

View more

When and how ruling out cystic fibrosis in adult patients with bronchiectasis

View more

Focus on the cetirizine use in clinical practice: a reappraisal 30 years later

View more

Ambroxol for the treatment of children with acute and chronic respiratory diseases: an overview of efficacy and safety

View more

Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure

View more

Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review

View more

FAQS